5
The who’s who of the biotech industry relies on Austria. Takeda Vienna is home to one of the world’s largest plasma processing plants and its global R&D centre for plasma innovations. The Japanese firm is once again making a three-digit million euro investment for biopharmaceutical research and development in Vienna. This comprises the largest R&D investment in Austria ever by Takeda, which has operated in the country for nearly 70 years. Approximately 250 researchers will work at the facility, focusing on biotechnologically produced pharmaceuticals and gene therapies. All this is accompanied by the digitisation of R&D work supported by…